Literature DB >> 18955725

Geographical differences in the occurrence of Alzheimer's disease mortality: United States versus Puerto Rico.

Raul Figueroa1, Kyle Steenland, Jessica R MacNeil, Allan I Levey, Irving E Vega.   

Abstract

Since the implementation of the 10th International Classification of Disease in 1999, the trend in Alzheimer's disease mortality rate has not been reported. Here, the age-adjusted Alzheimer's disease mortality rate in Puerto Rico and United States from 1999 to 2004 was analyzed. The results showed an increasing trend in Alzheimer's disease mortality rate in both the United States and Puerto Rico. However in Puerto Rico, the Alzheimer's disease mortality rate (32.4/100,000) was higher than that observed in United States (20.9/100,000). Interestingly, the Alzheimer's disease mortality rate of Puerto Ricans living in Puerto Rico is much higher than Puerto Ricans living in the United States. The higher occurrence of Alzheimer's disease mortality in Puerto Rico versus the United States could be explained by factors such as coding practices, genetics, socioeconomics, and health care. These results highlight the need for comprehensive studies on factors that may influence diagnosis, death certificate coding practices, and development of Alzheimer's disease pathology in different geographical regions.

Entities:  

Mesh:

Year:  2008        PMID: 18955725      PMCID: PMC3640495          DOI: 10.1177/1533317508321909

Source DB:  PubMed          Journal:  Am J Alzheimers Dis Other Demen        ISSN: 1533-3175            Impact factor:   2.035


  17 in total

1.  Incidence of AD in African-Americans, Caribbean Hispanics, and Caucasians in northern Manhattan.

Authors:  M X Tang; P Cross; H Andrews; D M Jacobs; S Small; K Bell; C Merchant; R Lantigua; R Costa; Y Stern; R Mayeux
Journal:  Neurology       Date:  2001-01-09       Impact factor: 9.910

2.  Gender differences in the incidence of AD and vascular dementia: The EURODEM Studies. EURODEM Incidence Research Group.

Authors:  K Andersen; L J Launer; M E Dewey; L Letenneur; A Ott; J R Copeland; J F Dartigues; P Kragh-Sorensen; M Baldereschi; C Brayne; A Lobo; J M Martinez-Lage; T Stijnen; A Hofman
Journal:  Neurology       Date:  1999-12-10       Impact factor: 9.910

3.  Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families.

Authors:  E H Corder; A M Saunders; W J Strittmatter; D E Schmechel; P C Gaskell; G W Small; A D Roses; J L Haines; M A Pericak-Vance
Journal:  Science       Date:  1993-08-13       Impact factor: 47.728

4.  Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease.

Authors:  A Goate; M C Chartier-Harlin; M Mullan; J Brown; F Crawford; L Fidani; L Giuffra; A Haynes; N Irving; L James
Journal:  Nature       Date:  1991-02-21       Impact factor: 49.962

5.  Are sex and educational level independent predictors of dementia and Alzheimer's disease? Incidence data from the PAQUID project.

Authors:  L Letenneur; V Gilleron; D Commenges; C Helmer; J M Orgogozo; J F Dartigues
Journal:  J Neurol Neurosurg Psychiatry       Date:  1999-02       Impact factor: 10.154

Review 6.  Genetics of Alzheimer's disease: a centennial review.

Authors:  Nilüfer Ertekin-Taner
Journal:  Neurol Clin       Date:  2007-08       Impact factor: 3.806

Review 7.  Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria.

Authors:  Bruno Dubois; Howard H Feldman; Claudia Jacova; Steven T Dekosky; Pascale Barberger-Gateau; Jeffrey Cummings; André Delacourte; Douglas Galasko; Serge Gauthier; Gregory Jicha; Kenichi Meguro; John O'brien; Florence Pasquier; Philippe Robert; Martin Rossor; Steven Salloway; Yaakov Stern; Pieter J Visser; Philip Scheltens
Journal:  Lancet Neurol       Date:  2007-08       Impact factor: 44.182

8.  The association between genetic variants in SORL1 and Alzheimer disease in an urban, multiethnic, community-based cohort.

Authors:  Joseph H Lee; Rong Cheng; Nicole Schupf; Jennifer Manly; Rafael Lantigua; Yaakov Stern; Ekaterina Rogaeva; Yosuke Wakutani; Lindsay Farrer; Peter St George-Hyslop; Richard Mayeux
Journal:  Arch Neurol       Date:  2007-04

Review 9.  Interaction between genes and environment in neurodegenerative diseases.

Authors:  Alexis Elbaz; Carole Dufouil; Annick Alpérovitch
Journal:  C R Biol       Date:  2007-04-09       Impact factor: 1.583

10.  The prevalence and 3-year incidence of dementia in older Black and White community residents.

Authors:  G G Fillenbaum; A Heyman; M S Huber; M A Woodbury; J Leiss; K E Schmader; A Bohannon; B Trapp-Moen
Journal:  J Clin Epidemiol       Date:  1998-07       Impact factor: 6.437

View more
  5 in total

Review 1.  Alzheimer's Disease in the Latino Community: Intersection of Genetics and Social Determinants of Health.

Authors:  Irving E Vega; Laura Y Cabrera; Cassandra M Wygant; Daniel Velez-Ortiz; Scott E Counts
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

2.  Profiling of Alzheimer's disease patients in Puerto Rico: A comparison of two distinct socioeconomic areas.

Authors:  Clara L Camacho-Mercado; Raúl Figueroa; Heriberto Acosta; Steven E Arnold; Irving E Vega
Journal:  SAGE Open Med       Date:  2016-01-29

3.  Dementia Research in the Caribbean Hispanic Islands: Present Findings and Future Trends.

Authors:  Daisy Acosta; Jorge J Llibre-Guerra; Ivonne Z Jiménez-Velázquez; Juan J Llibre-Rodríguez
Journal:  Front Public Health       Date:  2021-01-18

Review 4.  The role of geographic information system and global positioning system in dementia care and research: a scoping review.

Authors:  Neda Firouraghi; Behzad Kiani; Hossein Tabatabaei Jafari; Vincent Learnihan; Jose A Salinas-Perez; Ahmad Raeesi; MaryAnne Furst; Luis Salvador-Carulla; Nasser Bagheri
Journal:  Int J Health Geogr       Date:  2022-08-04       Impact factor: 5.310

Review 5.  Geographical variation in dementia: systematic review with meta-analysis.

Authors:  Tom C Russ; G David Batty; Gena F Hearnshaw; Candida Fenton; John M Starr
Journal:  Int J Epidemiol       Date:  2012-07-13       Impact factor: 7.196

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.